Visa Inc. A diskutieren
Visa Inc. A
WKN: A0NC7B / Symbol: V / Name: Visa / Aktie / Kommerzielle Dienstleistungen / Large Cap /
300,60 €
-0,61 %
Visa Inc. (NYSE: V) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $400.00 price target on the stock.
Ratings data for V provided by MarketBeat
Visa Inc. (NYSE: V) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Ratings data for V provided by MarketBeat
Visa Inc. (NYSE: V) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $425.00 price target on the stock.
Ratings data for V provided by MarketBeat
Visa Inc. (NYSE: V) had its "overweight" rating re-affirmed by analysts at Barclays PLC.
Ratings data for V provided by MarketBeat
Visa Inc. (NYSE: V) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $390.00 to $391.00. They now have an "outperform" rating on the stock.
Ratings data for V provided by MarketBeat
Visa Inc. (NYSE: V) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating on the stock.
Ratings data for V provided by MarketBeat
Visa Inc. (NYSE: V) had its price target lowered by analysts at Truist Financial Corporation from $400.00 to $397.00. They now have a "buy" rating on the stock.
Ratings data for V provided by MarketBeat
Visa Inc. (NYSE: V) had its price target raised by analysts at Morgan Stanley from $386.00 to $402.00. They now have an "overweight" rating on the stock.
Ratings data for V provided by MarketBeat
Visa Inc. (NYSE: V) had its price target raised by analysts at UBS Group AG from $405.00 to $415.00. They now have a "buy" rating on the stock.
Ratings data for V provided by MarketBeat
Visa Inc. (NYSE: V) had its "overweight" rating re-affirmed by analysts at Barclays PLC.
Ratings data for V provided by MarketBeat
Visa Inc. (NYSE: V) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc..
Ratings data for V provided by MarketBeat
Visa (NYSE:V) was given a new $410.00 price target on by analysts at Robert W. Baird. They now have an "outperform" rating on the stock.
Ratings data for V provided by MarketBeat
Visa (NYSE:V) had its "overweight" rating reaffirmed by analysts at KeyCorp. They now have a $405.00 price target on the stock.
Ratings data for V provided by MarketBeat
Visa (NYSE:V) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $450.00 price target on the stock.
Ratings data for V provided by MarketBeat
Visa (NYSE:V) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Ratings data for V provided by MarketBeat
Visa (NYSE:V) was given a new $398.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for V provided by MarketBeat
Visa (NYSE:V) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $408.00 price target on the stock, up previously from $398.00.
Ratings data for V provided by MarketBeat
Visa (NYSE:V) had its price target lowered by analysts at Macquarie from $425.00 to $410.00. They now have an "outperform" rating on the stock.
Ratings data for V provided by MarketBeat
Visa (NYSE:V) was upgraded by analysts at Hsbc Global Res from a "hold" rating to a "strong-buy" rating.
Ratings data for V provided by MarketBeat
Visa (NYSE:V) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $382.00 price target on the stock.
Ratings data for V provided by MarketBeat
Neueste Beiträge
StockNews_com in Acadia Pharmaceuticals diskutieren